Behind the Headlines: Episode 13; Budget Cuts, Reshoring, and Biotech Buyouts
March 20th 2025Neil Hunter, Alex Philippidis, Joanna Sadowska, PhD, EMBA, and Carl Schoellhammer, PhD go behind the headlines to discuss the impact of federal budget cuts on future pharma investments, reshoring efforts, and biotech buyouts.
DCAT Week 2025: Expanding Sterile Injectables Capacity
March 18th 2025PharmTech Group interviewed Lee Karras of Noramco live on site at DCAT Week 2025, shortly after the company announced a $25 million investment in sterile injectable manufacturing capabilities at its Halo Pharma facility in New Jersey.
Industry Outlook 2025: US Political Motivations and Legislative Discussions
March 11th 2025Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments, in an interview with Pharmaceutical Technology®.
International Women’s Day 2025: A Promising Future for Gender Diversity in Pharma
March 8th 2025In an interview with Pharmaceutical Technology®, Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Industry Outlook 2025: Consolidating Data and Relaxing Regulations on AI
March 6th 2025In an interview with Pharmaceutical Technology®, Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Behind the Headlines Episode 12–Cell and Gene Therapies, New Genomics Tools, and Recent Partnerships
March 5th 2025Brian Feth, Xcell Biosciences; Thomas Heathman, Ori Biotech; and Matthew Lauber, Waters Corporation go behind the headlines and discuss commercialization challenges in the cell and gene therapy space; advances in new genomics tools from Roche, Illumina, and Eikon; and the latest development and manufacturing partnerships.
Industry Outlook 2025: Interesting Relations and Detailed Discussions on Data
February 27th 2025Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes in an interview with Pharmaceutical Technology®.
Ask the Expert: Complying with 21 CFR 211.110
February 20th 2025In this episode of the Ask the Expert video series, Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, discuss the implications of FDA’s new draft guidance on complying with 21 CFR 211.110.
Industry Outlook 2025: Personalizing Precision Medicine and Adopting AI
February 20th 2025Pharmaceutical Technology® chatted with Preeya Beczek, managing director and co-founder of Beczek.COM, about industry trends from 2024 and which of those might impact the industry in 2025, including the big trend of AI.
Behind the Headlines Episode 11–GLP-1 Patent Expiry, Recent Acquisitions, and Indirect Costs Capping
February 18th 2025Benjamin McLeod, Abhi Naravane, PhD, MBA, and Marianna Tcherpakov PhD go behind the headlines to talk about the latest big acquisitions, GLP-1 Super Bowl advertising, and changes in NIH funding.